Swedish Orphan Biovitrum AB (publ) (BIOVF)

OTCMKTS · Delayed Price · Currency is USD

37.00

+0.41 (1.13%)

At close: Jan 14, 2026

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Haematology	13.37B
Haematology Growth	23.44%
Immunology	7.64B
Immunology Growth	14.31%
Specialty Care	1.12B
Specialty Care Growth	-12.58%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	8.15B
United States Growth	10.65%
Europe	7.85B
Europe Growth	119.00%
Global	2.72B
Global Growth	90.47%
Rest of the World	2.65B
Rest of the World Growth	8.82%
Sweden	660.00M
Sweden Growth	-1.05%
North America	93.00M
North America Growth	20.78%